ArticleOncotarget2014

Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.

Adrienne L Watson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.